Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.

Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.

Item
http://www.wikidata.org/entity/Q38181565
Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysisThe pharmacogenomics of epilepsy.Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and children.Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to go.Pharmacogenomics in epilepsy.Individualized Dosing Algorithms and Therapeutic Monitoring for Antiepileptic Drugs.Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese.Evaluating the Role of Genetic Variants on first-line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin Monotherapy and its Serum Drug Levels.
P2860

Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.

Item
http://www.wikidata.org/entity/Q38181565
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.
@en
type
label
Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.
@en
prefLabel
Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.
@en
P2093
P2860
P304
P31
P356
10.1517/17425255.2014.872630
P407
P433
P478
P577
P698